This may be a turning point in treating neurodegenerative diseases

Success in trials for Huntington ’s and Spinal Muscular Atrophy raises hopes that diseases such as Alzheimer’s and ALS could be tackled using a new class of drugsThey are diseases that threaten more than physical health: memories, personality, and the ability to move and speak are incrementally stolen. And until this year neurodegenerative diseases, from Alzheimer ’s toALS, had been entirely unstoppable.However, abreakthrough in Huntington ’s disease this week suggests this bleak picture could be about to change. The landmark trial was the first to show that the genetic defect that causes Huntington ’s could be corrected, raising hopes that the drug will become the first to slow the progress of the disease – or even stop it.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Medical research Neuroscience Alzheimer's Motor neurone disease Parkinson's disease Genetics Drugs Health Biology Source Type: news